BACKGROUND: Despite concern for adverse perinatal outcomes in women with diabetes mellitus before pregnancy, recent data on the prevalence of pregestational type 1 and type 2 diabetes mellitus in the United States are lacking. OBJECTIVE: The purpose of this study was to estimate changes in the prevalence of overall pregestational diabetes mellitus (all types) and pregestational type 1 and type 2 diabetes mellitus and to estimate whether changes varied by race-ethnicity from 1996e2014. STUDY DESIGN: We conducted a cohort study among 655,428 pregnancies at a Northern California integrated health delivery system from 1996e2014. Logistic regression analyses provided estimates of prevalence and trends. RESULTS: The age-adjusted prevalence (per 100 deliveries) of overall pregestational diabetes mellitus increased from 1996e1999 to 2012e2014 (from 0.58 [95% confidence interval, 0.54e0.63] to 1.06 [95% confidence interval, 1.00e1.12]; P trend <.0001). Significant increases occurred in all racial-ethnic groups; the largest relative increase was among Hispanic women (121.8% [95% confidence interval, 84.4e166.7]); the smallest relative increase was among non-Hispanic white women (49.6% [95% confidence interval, 27.5e75.4]). The age-adjusted prevalence of pregestational type 1 and type 2 diabetes mellitus increased from 0.14 (95% confidence interval, 0.12e0.16) to
D ata on trends in the prevalence of pregestational diabetes mellitus and whether trends in the prevalence of pregestational type 1 and type 2 diabetes mellitus vary by race-ethnicity in the United States are needed. It has been reported that the predicted increases in the number of youths who will be living with type 1 and type 2 diabetes mellitus by the year 2050 will be primarily among youths of minority racial-ethnic groups, 1 thus a similar racial-ethnic disparity in the prevalence of pregestational type 1 and type 2 diabetes mellitus might be expected. Three reports suggest that the prevalence of pregestational diabetes mellitus increased among pregnant women in the United States up to 2010. [2] [3] [4] The only study that reported on trends in the prevalence of pregestational type 1 and type 2 diabetes mellitus did not include racial-ethnic specific prevalence estimates, and data were limited to 2004. 3 Therefore, it is unknown whether increases in the prevalence of pregestational type 1 and type 2 diabetes mellitus vary by race-ethnicity.
Pregestational diabetes mellitus is associated with an increased risk of adverse perinatal outcomes that include preeclampsia, 5, 6 retinopathy, 7 early fetal loss, 8, 9 stillbirth, 10 macrosomia, 11 birth injuries associated with large fetal size, and infant death. 10, 12 Given the burden of type 1 and type 2 diabetes mellitus during pregnancy and recent changes in the racial-ethnic composition of women of reproductive age in the United States, understanding changes in the prevalence of pregestational diabetes mellitus, overall and by population subgroups, is important for informing health systems and clinicians of the resources that are required for the preconception and obstetric care of young women with diabetes mellitus.
The objective of this study was to estimate trends in the prevalence of overall pregestational diabetes mellitus (ie, all types) and pregestational type 1 and type 2 diabetes mellitus (hereafter referred to as type 1 and type 2 diabetes mellitus) between 1996 and 2014 and to examine whether changes in prevalence vary by race-ethnicity. Original Research ajog.org
Materials and Methods
The study setting is Kaiser Permanente Northern California (KPNC), a large integrated healthcare delivery system that consists of 44 medical centers and 13 delivery hospitals that provide healthcare for approximately 33,000 deliveries per year. Analysis of US census data demonstrates that KPNC members are representative of the geographic region served with regards to race-ethnicity and education and differ only slightly at the extremes of the income distribution. 13, 14 Women use the same KPNC medical center for general medicine and obstetric care, which includes all laboratory testing. KPNC maintains complete databases of all hospitalizations, outpatient visits, laboratory tests, and medications that are dispensed through an electronic health record system, in addition to housing a Diabetes Registry 15, 16 and a Pregnancy Glucose Tolerance and Gestational Diabetes Registry. 17 All laboratory tests performed during and outside of pregnancy are determined at a single location, the KPNC Regional Laboratory, which participates in the College of American Pathologists' accreditation and monitoring program.
This cohort study was conducted among pregnancies that delivered at 20 weeks gestation between January 1, 1996, and December 31, 2014. Deliveries were identified by a method previously described. 17 Clinically recognized diabetes mellitus before a pregnancy (ie, overall pregestational diabetes mellitus) was ascertained through the KPNC Diabetes Registry. Study methods and description of the KPNC Diabetes Registry (99% sensitivity based on chart review validation) have been published previously. 15, 16 Briefly, in the Diabetes Registry, clinical recognition of diabetes mellitus is based on meeting any of the following criteria: (1) inpatient diagnosis of diabetes mellitus (principal diagnosis of ICD-9: 250), (2) 2 outpatient diagnoses of diabetes mellitus with ICD-9: 250 (excluding those collected in the emergency room, optometry, or ophthalmology departments), 17 Pregestational diabetes mellitus types were defined with the use of a combination of ICD-9 codes and insulin use in the following manner: (1) identified as pregestational type 2 diabetes mellitus if insulin was never used or used only during pregnancy (n¼3200) or if insulin was used during pregnancy and in the year before conception and only ICD-9 codes for type 2 diabetes mellitus (ICD-9 250.x0, 250.x2) were present and no ICD-9 codes for type 1 diabetes mellitus (ICD-9 250.x1, 250.x3) were present (n¼772); (2) identified as pregestational type 1 diabetes mellitus if insulin was used during pregnancy and in the year before conception and ICD-9 codes for type 1 diabetes mellitus were present (n¼1250). Diabetes mellitus type was assigned "unknown" if neither of the aforementioned definitions were met and the pregnancy was excluded (n¼34). Among the 1250 pregnancies defined has having pregestational type 1 diabetes mellitus, approximately 90% of them had at least 2 diagnoses of type 1 diabetes mellitus on different occasions.
Maternal age was obtained from electronic health records; self-reported race-ethnicity was obtained from the birth certificate. This study was approved by the human subjects committees of KPNC and the State of California.
Statistical analyses
The age-adjusted prevalence of pregestational diabetes mellitus per 100 deliveries (95% confidence interval [CI]) was obtained from logistic regression analyses that were conducted among 655,428 pregnancies that delivered at 20 weeks gestation from 1996e2014. Time trends in the age-adjusted prevalence of overall pregestational diabetes mellitus and pregestational type 1 and type 2 diabetes mellitus (per 100 deliveries) were evaluated among all women and by race-ethnicity, with years grouped 1996e1999, 2000e2002, 2003e2005, 2006e2008, 2009e2011 and 2012e2014. Differences by raceethnicity were obtained from logistic regression models that included the racial-ethnic groups as dummy variables. The probability values for the parameters that were calculated for each racialethnic group were obtained from maximum likelihood estimation. All analyses were performed with SAS software (version 9.3; SAS Institute Inc, Cary, NC).
Results
Among 655,428 pregnancies that were delivered at 20 weeks gestation between January 1, 1996, and December 31, 2014, at KPNC, 5256 pregnancies (0.8%) were identified as affected by pregestational diabetes mellitus. Of these, 1250 pregnancies (23.8%) were classified as type 1 diabetes mellitus, and 3972 pregnancies (75.6%) were classified as type 2 diabetes mellitus; for 34 pregnancies (0.6%), diabetes mellitus type was classified as unknown and were excluded. In 2012e2014, the highest ageadjusted prevalence of pregestational type 1 diabetes mellitus was observed in non-Hispanic white women (0.36 per 100 deliveries [95% CI, 0.31e0.43]), followed by African American women (0.27 per 100 deliveries [95% CI, 0.17e0.43]). However, the prevalence estimates for non-Hispanic white women were only significantly higher than the prevalence estimates that were 
Comments
In a large, diverse cohort of pregnant women, we observed an alarming 81.3% increase in the prevalence of overall pregestational diabetes mellitus between 1996e1999 and 2012e2014. Prevalence increases were observed for both type 1 and type 2 diabetes mellitus, and significant racial and ethnic disparities in the relative prevalence increases were observed for type 1 and type 2 diabetes mellitus.
The increase in the prevalence of pregestational diabetes mellitus may be due to increases in the proportion of diabetic women who are able to become and remain pregnant through 20 weeks gestation and is likely related to improvements in preconception and prenatal care for women with diabetes mellitus. The observed increase in the prevalence of pregestational diabetes mellitus may also be due to increases in the incidence of diabetes mellitus among reproductive-aged women. Although increases in the incidence of type 1 diabetes mellitus have also been reported, 19 ,20 the causes are largely unknown. Increases in the incidence of type 2 diabetes mellitus mostly likely are due to increases in the prevalence of overweight and obesity among women of reproductive age in the United States during the study period. 21, 22 We observed significant racial-ethnic disparities in the increases in the prevalence of pregestational diabetes mellitus overall and by subtype. Non-Hispanic white women had the largest relative increase in the prevalence of pregestational type 1 diabetes mellitus and the smallest relative increase in pregestational type 2 diabetes mellitus. Women from racial-ethnic minority groups (Hispanic, African American, and Asian women) experienced dramatic increases in the prevalence of pregestational type 2 diabetes mellitus, specifically, higher relative increases than that observed among non-Hispanic white women. The disproportionate increase in pregestational type 2 diabetes mellitus among racial-ethnic minority groups likely, in part, is due to increases in the prevalence of overweight and obesity among African American and Hispanic women in the United States during the study period; however, national data lack information on trends in overweight and obesity among Asian women. 21, 22 Our findings are in agreement with previous studies that have reported trends in the prevalence of pregestational diabetes mellitus in the United States and Canada. The most recent study, which used hospital discharge data from 19 states, reported that age-standardized prevalence of pregestational diabetes mellitus increased from 0.65% per 100 deliveries in 2000 to 0.89% per 100 deliveries in 2010. 4 A study at Kaiser Permanente Southern California found that the age and race-ethnicity adjusted prevalence of pregestational diabetes mellitus more than doubled from 1999e2005 (from 0.81e1.82 per 100 deliveries).
2 A large, population-based study in Ontario, Canada, similarly revealed that the ageadjusted prevalence of pregestational diabetes mellitus doubled from 1996e2010. 23 The only previous study to examine trends in the prevalence of pregestational type 1 and type 2 diabetes mellitus was conducted for 1994e2004, used hospital discharge diagnoses to define diabetes mellitus type, and did not have data on race-ethnicity 3 ; nevertheless, the reported increases in type 1 and type 2 diabetes mellitus were similar to those observed in our population up to 2004: the crude prevalence of type 1 increased from 0.24e0.33% per 100 deliveries; the prevalence of type 2 diabetes mellitus increased from 0.24e0.84% per 100 deliveries. 3 The increased prevalence of pregestational diabetes mellitus is consistent with reports of substantial increases in the prevalence of diabetes mellitus in the US population in general over the past 2 decades 24 and is of great concern because of the increased risk of maternal and neonatal complications that are associated with pregestational diabetes mellitus. In addition, given the growing body of evidence that suggests that in utero exposure to diabetes mellitus is associated with increased risk of obesity and diabetes mellitus in the offspring, 25, 26 increases in pregestational diabetes mellitus suggest a snowballing of the intergenerational transfer of these chronic conditions.
The main strength of the current study is the use of the KPNC Diabetes Registry 15, 16 to assess diabetes mellitus status before conception, in addition to using data on insulin use (in the year before conception and during pregnancy) and ICD-9 codes to classify women as having type 1 or type 2 diabetes mellitus. Although we were unable to validate our classification scheme against etiologic criteria (ie, presence of antibodies for type 1 and the presence of insulin resistance for type 2), previous investigations of trends in pregestational diabetes mellitus were either unable to assess diabetes mellitus type 2, 4 or relied on hospital discharge diagnosis at delivery for the designation of diabetes mellitus type. 3 In addition, our results are consistent with race-ethnic specific trends in prevalence of type 1 diabetes mellitus reported among youth in the United States to 2009 in the SEARCH study, 27 where type 1 diabetes mellitus was defined by physician diagnosis and validated by etiologic criteria, such as presence of diabetes mellitus antibody. The use of the KPNC Pregnancy Glucose Tolerance and Gestational Diabetes Registry 17 to identify and exclude women with gestational diabetes mellitus, as determined by objective glucose measurements, is another strength.
Body mass index data were unavailable; thus, we were not able to control for trends of increases in the prevalence ajog.org OBSTETRICS Original Research maternal obesity. Trends in maternal body mass index may have explained, at least in part, the observed increases in the prevalence of type 2 diabetes mellitus and the observed racial and ethnic disparities. The racial and ethnic disparities that were observed in this study may not be generalizable to analyses that use more granular categories of race-ethnicity. In addition, differential rates of early fetal loss between type 1 and type 2 diabetes mellitus could have introduced bias to our study, although available evidence suggests that such differential rates of fetal loss are unlikely. 28 In summary, the prevalence of overall pregestational diabetes mellitus and pregestational type 1 and type 2 diabetes mellitus increased from 1996e1999 to 2012e2014. Significant racial-ethnic disparities were observed for the increases in pregestational type 1 and type 2 diabetes mellitus. Given the increased prevalence of pregestational diabetes mellitus in pregnant women and projections for sustained or further increases in subsequent generations, prevention strategies and health systemebased interventions of preconception care targeting young women, especially those from minority groups, are needed to optimize the health of mothers and their infants and to reduce the healthcare cost of diabetes mellitus. n
